Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Indaptus Therapeutics, Inc. (INDP) had Return on Equity of -15.78% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-1.79M |
|
-- |
|
-- |
|
$1.81M |
|
$-1.81M |
|
$0.01M |
|
$-1.79M |
|
$-1.79M |
|
$-1.79M |
|
$-1.79M |
|
$-1.79M |
|
$-1.79M |
|
$-1.81M |
|
$-1.81M |
|
116.13M |
|
116.13M |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$11.99M |
|
-- |
|
-- |
|
$11.99M |
|
$0.62M |
|
-- |
|
-- |
|
$0.62M |
|
$11.37M |
|
$11.37M |
|
$11.37M |
|
133.24M |
|
| Cash Flow Statement Financials | |
$-8.94M |
|
$-4.00M |
|
$11.98M |
|
$8.51M |
|
$7.55M |
|
$-0.95M |
|
$0.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
19.48 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.94M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-15.78% |
-15.78% |
|
-14.97% |
|
-15.78% |
|
$0.09 |
|
$-0.08 |
|
$-0.08 |
|